T Phan Selected Research

T Phan Research Topics

5	Neoplasms (Cancer) 10/2016 - 01/2001
4	Hemorrhage 10/2016 - 04/2002
3	Pancreatic Neoplasms (Pancreatic Cancer) 04/2002 - 01/2001
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 10/2015
2	Adenocarcinoma 01/2001 - 01/2001
1	Breast Neoplasms (Breast Cancer) 09/2018
1	Stroke (Strokes) 01/2017
1	Colonic Neoplasms (Colon Cancer) 10/2016
1	Fever (Fevers) 10/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2016
1	Heart Diseases (Heart Disease) 10/2016
1	Inflammation (Inflammations) 10/2016
1	Pain (Aches) 10/2016
1	Hypersensitivity (Allergy) 06/2013
1	Peanut Hypersensitivity (Peanut Allergy) 06/2013
1	Alcoholism (Alcohol Abuse) 04/2005
1	Gallbladder Diseases (Gall Bladder Disease) 04/2004
1	Weight Loss (Weight Reduction) 04/2002
1	Infections 01/2001
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2000
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2000
1	Multiple Sclerosis 05/2000

3	Gemcitabine FDA Link 04/2002 - 01/2001
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2016 - 08/2011
2	Phenobarbital (Luminal)FDA Link 01/2016 - 08/2011
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 08/2011
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Analgesics (Analgesic Drugs)IBA 10/2016
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2016
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 10/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016
1	hypoxanthine arabinoside (ara-H)IBA 06/2013
1	AllergensIBA 06/2013
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2013
1	Peptides (Polypeptides)IBA 06/2013
1	Evans Blue (Blue, Evans)FDA Link 08/2011
1	Bile Acids and Salts (Bile Acids)IBA 08/2011
1	Pharmaceutical PreparationsIBA 04/2005
1	Fluorouracil (Carac)FDA LinkGeneric 04/2002
1	cytomegalovirus-specific hyperimmune globulinIBA 01/2001
1	Biological ProductsIBA 01/2001
1	InterferonsIBA 05/2000
1	Immunologic Factors (Immunomodulators)IBA 05/2000

4	Radiotherapy 09/2018 - 01/2001
2	Therapeutics 04/2002 - 01/2001
1	Secondary Prevention 01/2017
1	Chemoradiotherapy 01/2017
1	Brachytherapy 10/2015
1	Immunotherapy 06/2013
1	Ligation 08/2011
1	Laparoscopic Cholecystectomy 04/2004
1	Length of Stay 04/2002
1	Drug Therapy (Chemotherapy) 09/2001